-
An Israeli airstrike killed 20 people in central Gaza, mostly women and children, on Sunday, as fighting raged and Israel's leaders aired divisions over who should govern Gaza after the war.
-
Postpartum care in America leaves most facing a critical and often overlooked "fourth trimester" in isolation. Metro Detroit-based Fourth Tri Sanctuary offers support.
-
NPR's Scott Simon speaks with Amy McCarthy, a reporter for the food blog Eater and fan of Red Lobster, about the closure of dozens of the chain's restaurants.
-
A historically Black university in North Carolina may have had its last graduation as the school fights for its accreditation.
-
Cash-for-votes is such a pervasive problem in India that the election commission says it seized nearly half a billion dollars of cash and inducements before the polls even opened last month.
-
NPR's Scott Simon talks with strategic studies professor Phillips O'Brien of the University of St. Andrews in Scotland about the significance of Russia's latest military offensive in Ukraine.
-
A flag flap for a Supreme Court justice, and both major presidential campaigns agree to debates, albeit earlier than is traditional, with some rule changes.
-
The U.S. military says the first shipment of aid has moved ashore into Gaza over a new, massive floating pier. It wants to scale up to 150 trucks entering Gaza per day.
-
There's a lot of finger-pointing in Slovakia following the assassination attempt this week on its prime minister. It's another example of political violence that's been taking place in Europe of late.
-
A Crimean Tatar couple in Ukraine, displaced by Russian troops, sees parallels to the Soviets' forced deportation of 200,000 Tatars from Crimea 80 years ago.
-
Today is the Preakness Stakes, the 2nd leg of horse racing's Triple Crown. NPR's Scott Simon talks to Jonathan Finn, author of "Beyond the Finish Line," about the history and tech of photo finishes.
-
Skin cancer is the most common cancer in the U.S. and we need all the protection we can get. So why is it so hard to get newer, more effective ingredients approved here?